Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.


             
 

Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.

Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.

Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.

Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.

Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.



NAVIGATION


         

 

This week at the annual conference of the American Academy of Neurological Surgeons (AANS), the Navigation and Intra-Operative Imaging division at Medtronic (NYSE: MDT) unveiled the latest in neurosciences surgical solutions, the StealthStation® S7TM system. The StealthStation S7 offers personalized navigation support for surgeon and surgical staff, with superior visualization and information display capabilities as well as streamlined workflow options.

 

The U.S. Food and Drug Administration has cleared for marketing a device that a doctor can use to see inside a blood vessel to assess the fat content of the plaque which builds up on the wall of the coronary arteries. Plaque is a deposit made up of cholesterol-rich fat, calcium, and other substances found in the blood. As plaque accumulates on the artery wall, it reduces blood flow to the heart muscle and increases the risk of blood clots which can lead to a heart attack.

 

A novel, three-dimensional (3-D) screening method for analyzing interactions between cells and new biomaterials could cut initial search times by more than half, researchers from the National Institute of Standards and Technology (NIST) and Rutgers University report in the new issue of Advanced Materials.

 

Researchers at the USC Information Sciences Institute have demonstrated a way to manufacture miniscule containers that might be used to deliver precise micro- or even nano- quantities of drugs. According to ISI project leader Peter Will, who is a research professor in the Viterbi School of Engineering, the new technique, described in a paper in the Journal of Micromechanics and Microengineering, is a two-step process.

 

May is Hypertension Awareness Month, and a new device in high blood pressure clinical trials is showing promise for treating U.S. hypertension (high blood pressure) patients whose condition is not controlled by drugs. Rheos® Hypertension (HT) Therapy is an implantable device designed to lower high blood pressure - the number one risk factor for stroke, heart and kidney disease.

 

A new, free white paper titled “Effectively Culturing Anaerobic Bacteria” is now available from Spiral Biotech, Inc. at: http://www.aicompanies.com/anoxomat. The white paper details new techniques for isolating and identifying anaerobic bacteria in organisms.

 

Cardica, Inc. (Nasdaq: CRDC) announced that the PAS-Port(R) Proximal Anastomosis System achieved its primary endpoint in a large, prospective, randomized pivotal clinical trial comparing graft vessel connections made using the PAS-Port system to conventional hand-sewn sutures during coronary artery bypass graft (CABG) procedures. Based on the positive data from the trial, Cardica submitted a 510(k) premarket notification to the U.S.

 

An article published in the open-access journal PLoS Onedescribes a new technique that uses cell phones for medical imagingpurposes. According to the authors, the new technology, developed byengineers at the University of California, Berkeley, couldimprovethe accessibility of medical imaging to billions of people aroundthe world.

 

Background Bone mineral density influences the risk of osteoporosis later in life and is useful in the evaluation of the risk of fracture. We aimed to identify sequence variants associated …

 

(No abstract is available for this citation)




April 2008
Mon Tue Wed Thu Fri Sat Sun
« Mar   May »
 123456
78910111213
14151617181920
21222324252627
282930